Blood group B trisaccharide (CAS 49777-14-2)

The Blood Group B trisaccharide, a carbohydrate consisting of three sugar units, has garnered significant attention in scientific research due to its implications in blood group antigen recognition and carbohydrate chemistry. One specific mechanism of action involves its interaction with blood group antigens present on the surface of red blood cells and various tissues. Researchers have utilized the Blood Group B trisaccharide as a model system to study carbohydrate-protein interactions, particularly those involved in blood group antigen recognition by lectins and antibodies. Understanding these interactions at the molecular level provides insights into immune responses, transplantation compatibility, and disease susceptibility. Moreover, the synthesis and structural characterization of the Blood Group B trisaccharide have contributed to the development of novel glycoconjugates, glycopeptides, and glycomimetics with potential applications in drug delivery, vaccine development, and diagnostic tools. Additionally, research efforts have focused on the enzymatic synthesis of Blood Group B trisaccharide analogs and the design of glycosylation strategies for the site-selective modification of biomolecules. Overall, the Blood Group B trisaccharide serves as a valuable tool in carbohydrate chemistry and glycobiology research, facilitating the exploration of carbohydrate-mediated biological processes.